In a study presented at the 25th international Aids conference in Munich on Tuesday, experts calculated that the minimum price for mass production of a generic version, based on the costs of lenacapavir’s ingredients and manufacturing, and allowing for 30% profit, was $40 a year , assuming 10 million people used it annually. In the long-term, 60 million people would probably need to take the drug preventatively to lower HIV levels significantly, they said.

Accounting for 30% profit seems reasonable to me.

Yet they're selling it for 1000x the price.

I understand they need to recoup research costs, but...

I have no other words.

[–] DessertStorms@lemmy.blahaj.zone 75 points 3 months ago* (last edited 3 months ago) (2 children)

I understand they need to recoup research costs, but…

Except they don't even need to do that, because, as is with most pharmaceuticals, the research was almost fully funded by the taxpayer.

And the 30% profit is for a generic product, so the research has already been done.

So yeah, 30% profit is of course much better than 3000%, but both are still obscene profiteering off of a lifesaving product paid for by, and then essentially withheld for ransom from, the general public.

[–] sir_pronoun@lemmy.world 22 points 3 months ago* (last edited 3 months ago) (2 children)

cough I believe if 40$ means 30% profit, then the cost to produce it is 28$. With the current price of it being 42,250$, this means the profit rate is 42,250$/28$*100%=150,892%.

In words, one hundred fifty thousand percent.

It's insane. Even if I am wrong and it's 3000% or 30,000% profit on a product funded by tax-payer money, it's insane and should be criminal.

[–] ArbitraryValue@sh.itjust.works 7 points 3 months ago* (last edited 3 months ago)

By that logic, the profit on software (which is free to copy) is infinite. You need to look at revenues minus costs for the whole company, not for the specific act of manufacturing a pill.

[–] DessertStorms@lemmy.blahaj.zone 3 points 3 months ago* (last edited 3 months ago)

Yeah, I wasn't really paying that much attention, and went off of OP reply's 30 x 1000 and then missed out a zero lol

But yeah, it only gets more despicable the more accurate the numbers are..

[–] BassTurd@lemmy.world 5 points 3 months ago (1 children)

This is the reason I hate when people use the "recoup" argument. If anyone takes any free money to do research, then that isn't an expense to that company. If I start my own thing, and use my own money to cure cancer, then I get to set the price to recoup my own losses. If the citizens paid for it through taxes or donations, then it should be cost + % profit. 30% is very fair.

[–] DessertStorms@lemmy.blahaj.zone 4 points 3 months ago* (last edited 3 months ago) (1 children)

Making profit off of medication (or any other basic survival need, for that matter, and especially if they're publicly funded) is and always will be immoral.

[–] BassTurd@lemmy.world 1 points 3 months ago (1 children)

This is a tough area for me. I think someone should be able to make a living researching and creating drugs. If that's all a company does they have to make money somehow. Admittedly, I have not put much thought past that, so there may be a simple solution. Research grants and other funding can pay salaries for a time, but that's a static income. Idk, I'm interested in how this would work without some amount of markup.

Unless profits means everything past salaries and stuff, then I do mostly agree. However I think there has to be allowance for cash on hand and further investment in infrastructure and all those other fun things needed to run and grow a business.

[–] sibachian@lemmy.ml 2 points 3 months ago

the problem is privatization for things that doesn't even make sense to privatize. if the cost of discovery is too high for a private entity then why are they the ones to supply it? they aren't actually doing anything but taking the foam from the top of what everyone else have collectively created. it's like the privatization of energy, a natural monopoly that literally runs into negative value through surplus. or the privatization of mandatory services that cannot be sustained at cost such as nation wide mail delivery. if it doesn't make sense the right choice is the only choice yet here we are lol.

[–] NovaPrime@lemmy.ml 13 points 3 months ago

The research cost recovery line they often yap about is bullshit itself though. The overwhelming majority of pharma research like the one involved here is subsidized through taxpayer dollars already, and they get tax incentives and write offs for failed research. If we had a sane, working government we could nationalize all life saving medications funded by public money while still allowing the inventors to enjoy some (reasonable) economic benefits from the research